B cell depletion therapies in autoimmune disease: advances and mechanistic insights
DSW Lee, OL Rojas, JL Gommerman - Nature reviews Drug discovery, 2021 - nature.com
In the past 15 years, B cells have been rediscovered to be not merely bystanders but rather
active participants in autoimmune aetiology. This has been fuelled in part by the clinical …
active participants in autoimmune aetiology. This has been fuelled in part by the clinical …
T follicular helper cell biology: a decade of discovery and diseases
S Crotty - Immunity, 2019 - cell.com
Hel** B cells and antibody responses is a major function of CD4+ T cells. It has been 10
years since the publication of Bcl6 as the lineage-defining transcription factor for T follicular …
years since the publication of Bcl6 as the lineage-defining transcription factor for T follicular …
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
Patients with rheumatoid arthritis (RA) receive highly targeted biologic therapies without
previous knowledge of target expression levels in the diseased tissue. Approximately 40 …
previous knowledge of target expression levels in the diseased tissue. Approximately 40 …
[HTML][HTML] Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven …
Background Although targeted biological treatments have transformed the outlook for
patients with rheumatoid arthritis, 40% of patients show poor clinical response, which is …
patients with rheumatoid arthritis, 40% of patients show poor clinical response, which is …
The roles of tertiary lymphoid structures in chronic diseases
Tertiary lymphoid structures (TLSs) are ectopic lymphoid tissues that drive antigen-specific
immune responses at sites of chronic inflammation. Unlike secondary lymphoid organs such …
immune responses at sites of chronic inflammation. Unlike secondary lymphoid organs such …
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
To define the cell populations that drive joint inflammation in rheumatoid arthritis (RA), we
applied single-cell RNA sequencing (scRNA-seq), mass cytometry, bulk RNA sequencing …
applied single-cell RNA sequencing (scRNA-seq), mass cytometry, bulk RNA sequencing …
B cells in rheumatoid arthritis: pathogenic mechanisms and treatment prospects
F Wu, J Gao, J Kang, X Wang, Q Niu, J Liu… - Frontiers in …, 2021 - frontiersin.org
Rheumatoid arthritis (RA) is a common, chronic, systemic autoimmune disease, and its
clinical features are the proliferation of joint synovial tissue, the formation of pannus and the …
clinical features are the proliferation of joint synovial tissue, the formation of pannus and the …
Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis
Despite nearly three decades of advances in the management of rheumatoid arthritis (RA), a
substantial minority of patients are exposed to multiple DMARDs without necessarily …
substantial minority of patients are exposed to multiple DMARDs without necessarily …
Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes
There is a current imperative to unravel the hierarchy of molecular pathways that drive the
transition of early to established disease in rheumatoid arthritis (RA). Herein, we report a …
transition of early to established disease in rheumatoid arthritis (RA). Herein, we report a …
Lymph node stromal cells: cartographers of the immune system
AT Krishnamurty, SJ Turley - Nature immunology, 2020 - nature.com
Lymph nodes (LNs) are strategically positioned at dedicated sites throughout the body to
facilitate rapid and efficient immunity. Central to the structural integrity and framework of LNs …
facilitate rapid and efficient immunity. Central to the structural integrity and framework of LNs …